Perrigo Stock Price, News & Analysis (NYSE:PRGO)

$88.25 +1.18 (+1.36 %)
(As of 02/23/2018 04:00 PM ET)
Previous Close$88.25
Today's Range$87.02 - $88.42
52-Week Range$63.68 - $95.93
Volume739,350 shs
Average Volume907,952 shs
Market Capitalization$12.26 billion
P/E Ratio-9.63
Dividend Yield0.74%
Beta0.76

About Perrigo (NYSE:PRGO)

Perrigo logoPerrigo Company plc is a global healthcare supplier that develops, manufactures and distributes over-the-counter (OTC) and generic prescription (Rx) pharmaceuticals, infant formulas, nutritional products, animal health, dietary supplements, active pharmaceutical ingredients (API), and medical diagnostic products, and Multiple Sclerosis drug Tysabri. Its businesses include Consumer Healthcare, Nutritionals, Rx Pharmaceuticals, API, Life Sciences and Other Businesses. The Company offers Healthcare Products across a range of product categories primarily in the United States, the United Kingdom, Mexico, Israel and Australia. In February 2014, the Company announced that it has acquired a basket of value-brand OTC products sold in Australia and New Zealand from Aspen Global Inc.

Receive PRGO News and Ratings via Email

Sign-up to receive the latest news and ratings for PRGO and its competitors with MarketBeat's FREE daily newsletter.

Industry, Sector and Symbol

Industry Drug Related Products
Sub-IndustryPharmaceuticals
SectorMedical
SymbolNYSE:PRGO
CUSIP71429010
Phone353-1709-4000

Debt

Debt-to-Equity Ratio0.54%
Current Ratio1.72%
Quick Ratio1.24%

Price-To-Earnings

Trailing P/E Ratio-9.63427947598253
Forward P/E Ratio18.05
P/E Growth1.85

Sales & Book Value

Annual Sales$5.28 billion
Price / Sales2.35
Cash Flow$8.20 per share
Price / Cash10.76
Book Value$41.55 per share
Price / Book2.12

Profitability

Trailing EPS($9.16)
Net Income$-4,012,800,000.00
Net Margins-26.28%
Return on Equity11.60%
Return on Assets5.44%

Miscellaneous

Employees12,800
Outstanding Shares140,840,000

Perrigo (NYSE:PRGO) Frequently Asked Questions

What is Perrigo's stock symbol?

Perrigo trades on the New York Stock Exchange (NYSE) under the ticker symbol "PRGO."

How often does Perrigo pay dividends? What is the dividend yield for Perrigo?

Perrigo announced a quarterly dividend on Thursday, February 15th. Investors of record on Friday, March 2nd will be paid a dividend of $0.19 per share on Tuesday, March 20th. This represents a $0.76 dividend on an annualized basis and a dividend yield of 0.86%. The ex-dividend date is Thursday, March 1st. This is a positive change from Perrigo's previous quarterly dividend of $0.16. View Perrigo's Dividend History.

How were Perrigo's earnings last quarter?

Perrigo Company plc (NYSE:PRGO) released its quarterly earnings data on Thursday, November, 9th. The company reported $1.39 EPS for the quarter, beating the Zacks' consensus estimate of $1.11 by $0.28. The company earned $1.22 billion during the quarter, compared to analyst estimates of $1.17 billion. Perrigo had a positive return on equity of 11.60% and a negative net margin of 26.28%. The business's quarterly revenue was down 2.0% on a year-over-year basis. During the same period last year, the firm posted $1.65 EPS. View Perrigo's Earnings History.

When will Perrigo make its next earnings announcement?

Perrigo is scheduled to release their next quarterly earnings announcement on Tuesday, February, 27th 2018. View Earnings Estimates for Perrigo.

Where is Perrigo's stock going? Where will Perrigo's stock price be in 2018?

17 analysts have issued 12-month target prices for Perrigo's shares. Their predictions range from $67.00 to $125.00. On average, they expect Perrigo's share price to reach $93.19 in the next twelve months. View Analyst Ratings for Perrigo.

What are Wall Street analysts saying about Perrigo stock?

Here are some recent quotes from research analysts about Perrigo stock:

  • 1. Cantor Fitzgerald analysts commented, "The CDC today released updated data on the 2017-2018 Influenza Season for Week 2, ending 01/13/18 (https://www.cdc.gov/flu/weekly/)." (1/19/2018)
  • 2. Canaccord Genuity analysts commented, "Date and time of first dissemination: May 22, 2017, 23:13 ET Date and time of production: May 22, 2017, 22:26 ET Target Price / Valuation Methodology: Perrigo Company – PRGO Discounted cash flow analysis supports an $86 valuation for PRGO shares Our discounted cash flow (DCF) analysis leads us to a price target of $86/share for PRGO. Our DCF considers our estimates through 2021, low-single-digit growth through 2033 and zero terminal growth thereafter. In addition, we expect Perrigo’s margin structure to remain somewhat consistent with our 2021 estimates." (5/22/2017)
  • 3. Deutsche Bank AG analysts commented, "We updated our model to reflect PRGO's divestiture of the Tysabri royalty stream to Royalty Pharma, which the company expects to complete this month, and preliminary assumptions for de-leveraging with the proceeds. The net effect of these changes was EPS dilution of ~15-20% over 2017-21 and a reduction in our DCF-derived PT to $87 (from $93), as our prior model reflected more value for the Tysabri royalty stream (~$3bn) relative to the upfront payment of $2.2bn. We have not factored in the potential sales-based milestone payments of $650mn, which could add ~$4/share to the theoretical DCF value if they hit. We continue to view PRGO as a unique asset with good value creation potential over the longer term, and are maintaining our Buy rating. Solid execution in the coming quarters will be critical for the stock, in our view." (3/14/2017)
  • 4. Jefferies Group LLC analysts commented, "Unaudited Q4 results were ahead of forecast. But the real story is FY17 guidance and it disappointed even after sharp cuts to Street models just 4 weeks ago. For the first time we can recall both rev & EPS will decline ' not a good story line for an OTC-focused company. Tysabri's sale helps de-lever PRGO but at the same time shrinks the EPS base by ~$2.20. Mgt continues to make moves to enhance shareholder value ' but it may take quite some time to do so." (2/28/2017)
  • 5. Royal Bank of Canada analysts commented, "While we expected a challenging 2017 guide, it was worse than we anticipated and came with an unexpected CFO departure. The strategic review around whether to sell Rx/generics will linger, limiting visibility but the conundrum is that we do not see upside in either scenario. We remain on the sidelines with target down to $68. Several additional thoughts after speaking with management this evening." (2/28/2017)

Who are some of Perrigo's key competitors?

Who owns Perrigo stock?

Perrigo's stock is owned by a number of of retail and institutional investors. Top institutional investors include BlackRock Inc. (6.11%), Franklin Resources Inc. (5.75%), Standard Life Aberdeen plc (1.74%), Parnassus Investments CA (1.57%), Goldman Sachs Group Inc. (1.48%) and Victory Capital Management Inc. (1.45%). Company insiders that own Perrigo stock include Gary K Kunkle Jr, Geoffrey M Parker, Herman Morris Jr, Jeffrey Needham, John Wesolowski, Judy L Brown, Michael J Jandernoa, Sharon Kochan, Thomas Farrington and Todd W Kingma. View Institutional Ownership Trends for Perrigo.

Who sold Perrigo stock? Who is selling Perrigo stock?

Perrigo's stock was sold by a variety of institutional investors in the last quarter, including BlackRock Inc., Standard Life Aberdeen plc, Goldman Sachs Group Inc., Gotham Asset Management LLC, Ontario Teachers Pension Plan Board, Deutsche Bank AG, Two Sigma Investments LP and Credit Agricole S A. Company insiders that have sold Perrigo company stock in the last year include Jeffrey Needham, John Wesolowski, Sharon Kochan, Thomas Farrington and Todd W Kingma. View Insider Buying and Selling for Perrigo.

Who bought Perrigo stock? Who is buying Perrigo stock?

Perrigo's stock was acquired by a variety of institutional investors in the last quarter, including Clal Insurance Enterprises Holdings Ltd, Victory Capital Management Inc., Systematic Financial Management LP, Renaissance Technologies LLC, Millennium Management LLC, Meitav Dash Investments Ltd., Smith Asset Management Group LP and Virtus Fund Advisers LLC. Company insiders that have bought Perrigo stock in the last two years include Geoffrey M Parker and John Wesolowski. View Insider Buying and Selling for Perrigo.

How do I buy Perrigo stock?

Shares of Perrigo can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Scottrade, Fidelity and Charles Schwab.

What is Perrigo's stock price today?

One share of Perrigo stock can currently be purchased for approximately $88.25.

How big of a company is Perrigo?

Perrigo has a market capitalization of $12.26 billion and generates $5.28 billion in revenue each year. The company earns $-4,012,800,000.00 in net income (profit) each year or ($9.16) on an earnings per share basis. Perrigo employs 12,800 workers across the globe.

How can I contact Perrigo?

Perrigo's mailing address is TREASURY BUILDING LOWER GRAND CANAL STREET, DUBLIN L2, 49010. The company can be reached via phone at 353-1709-4000 or via email at [email protected]


MarketBeat Community Rating for Perrigo (PRGO)

Community Ranking:  2.6 out of 5 (star star)
Outperform Votes:  536 (Vote Outperform)
Underperform Votes:  507 (Vote Underperform)
Total Votes:  1,043
MarketBeat's community ratings are surveys of what our community members think about Perrigo and other stocks. Vote "Outperform" if you believe the stock will outperform the S&P 500 over the long term. Vote "Underperform" if you believe the stock will underperform the S&P 500 over the long term. You may vote once every thirty days.

Analyst Ratings

Perrigo (NYSE:PRGO) Analysts' Consensus Rating

  (How are Consensus Ratings Calculated?)
Today30 Days Ago90 Days Ago180 Days Ago
Consensus Rating: BuyBuyBuyHold
Consensus Rating Score: 2.532.502.502.29
Ratings Breakdown: 0 Sell Rating(s)
8 Hold Rating(s)
9 Buy Rating(s)
0 Strong Buy Rating(s)
0 Sell Rating(s)
8 Hold Rating(s)
8 Buy Rating(s)
0 Strong Buy Rating(s)
0 Sell Rating(s)
7 Hold Rating(s)
7 Buy Rating(s)
0 Strong Buy Rating(s)
1 Sell Rating(s)
8 Hold Rating(s)
5 Buy Rating(s)
0 Strong Buy Rating(s)
Consensus Price Target: $93.19$91.60$91.00$84.73
Price Target Upside: 5.89% upside0.10% downside5.81% upside9.65% upside

Perrigo (NYSE:PRGO) Consensus Price Target History

Price Target History for Perrigo (NYSE:PRGO)

Perrigo (NYSE:PRGO) Analyst Ratings History

Show:
DateBrokerageActionRatingPrice TargetImpact on Share PriceDetails
2/23/2018Cantor FitzgeraldSet Price TargetBuy$107.00LowView Rating Details
2/1/2018Berenberg BankInitiated CoverageBuy$117.00LowView Rating Details
1/17/2018Canaccord GenuityReiterated RatingBuy$100.00LowView Rating Details
1/2/2018Leerink SwannInitiated CoverageMkt Perform -> Market Perform$90.00LowView Rating Details
12/8/2017ArgusUpgradeHold -> Buy$93.00MediumView Rating Details
12/4/2017BarclaysBoost Price TargetOverweight$93.00MediumView Rating Details
11/10/2017Jefferies GroupReiterated RatingHold$81.00N/AView Rating Details
11/10/2017Wells Fargo & CoBoost Price TargetMarket Perform$90.00N/AView Rating Details
11/10/2017Morgan StanleyBoost Price TargetEqual Weight$79.00 -> $92.00N/AView Rating Details
11/10/2017Royal Bank of CanadaUpgradeUnderperform -> Sector Perform$64.00 -> $86.00N/AView Rating Details
10/2/2017OppenheimerInitiated CoverageBuy$88.00LowView Rating Details
9/14/2017Deutsche BankBoost Price TargetBuy$88.00 -> $95.00LowView Rating Details
9/7/2017CIBCInitiated CoverageOutperform -> Outperform$88.00LowView Rating Details
8/11/2017Stifel NicolausReiterated RatingHoldLowView Rating Details
8/11/2017Goldman Sachs GroupUpgradeSell -> Neutral$66.00 -> $79.00MediumView Rating Details
4/22/2017B. RileyReiterated RatingNeutral$67.00MediumView Rating Details
2/28/2017GuggenheimReiterated RatingBuy$125.00N/AView Rating Details
11/10/2016JPMorgan Chase & Co.Set Price TargetHold$95.00N/AView Rating Details
11/11/2016Bank of AmericaUpgradeUnderperform -> NeutralN/AView Rating Details
8/11/2016Northland SecuritiesDowngradeOutperform -> Market Perform$123.00 -> $94.00N/AView Rating Details
6/17/2016BTIG ResearchReiterated RatingNeutralN/AView Rating Details
6/15/2016Raymond James FinancialReiterated RatingHoldN/AView Rating Details
(Data available from 2/24/2016 forward)

Earnings

Perrigo (NYSE:PRGO) Earnings History and Estimates Chart

Earnings by Quarter for Perrigo (NYSE:PRGO)

Perrigo (NYSE PRGO) Earnings History by Quarter

DateQuarterConsensus EstimateActual EPSRevenue EstimateActual RevenueRelease LinkConference CallDetails
2/27/2018$1.23N/AView Earnings Details
11/9/2017Q3 17$1.11$1.39$1.17 billion$1.22 billionViewN/AView Earnings Details
8/10/20176/30/2017$0.94$1.22$1.18 billion$1.24 billionViewN/AView Earnings Details
5/30/2017Q1 17$0.99$1.05$1.19 billion$1.19 billionViewN/AView Earnings Details
5/22/201712/31/2016$1.76$1.24$1.39 billion$1.33 billionViewN/AView Earnings Details
11/10/2016Q316$1.58$1.65$1.28 billion$1.40 billionViewN/AView Earnings Details
8/10/2016Q216$1.98$1.93$1.43 billion$1.48 billionViewListenView Earnings Details
5/12/2016Q116$1.75$1.75$1.35 billion$1.34 billionViewListenView Earnings Details
2/18/2016Q415$1.93$1.80$1.46 billion$1.42 billionViewListenView Earnings Details
10/22/2015Q3$1.73$1.76$1.42 billion$1.34 billionViewListenView Earnings Details
8/5/2015Q2$1.96$2.18$1.52 million$1.53 millionViewN/AView Earnings Details
4/21/2015Q315$1.78$1.85$1.10 billion$1.05 billionViewN/AView Earnings Details
2/5/2015Q215$1.79$1.82$1.09 billion$1.07 billionViewN/AView Earnings Details
11/6/2014Q115$1.44$1.40$997.90 million$951.50 millionViewN/AView Earnings Details
8/14/2014Q414$1.55$1.74$1.09 billion$1.14 billionViewN/AView Earnings Details
5/7/2014Q314$1.51$1.31$1.07 billion$1,000.00 millionViewN/AView Earnings Details
2/6/2014Q214$1.59$1.87$996.68 million$979.00 millionViewN/AView Earnings Details
10/31/2013Q114$1.40$1.52$900.10 million$933.00 millionViewN/AView Earnings Details
8/15/2013Q4 2013$1.56$1.57$999.08 million$967.20 millionViewN/AView Earnings Details
5/7/2013Q3 2013$1.44$1.42$935.44 million$919.83 millionViewN/AView Earnings Details
2/1/2013Q2 2013$1.31$1.36$881.84 million$882.96 millionViewN/AView Earnings Details
11/7/2012Q113$1.24$1.27$825.83 million$769.80 millionViewN/AView Earnings Details
8/16/2012$1.27$1.28ViewN/AView Earnings Details
5/8/2012$1.22$1.41ViewN/AView Earnings Details
2/7/2012$1.15$1.20ViewN/AView Earnings Details
10/27/2011$1.06$1.10ViewN/AView Earnings Details
8/16/2011$0.97$1.02ViewN/AView Earnings Details
5/3/2011$0.97$1.07ViewN/AView Earnings Details
2/1/2011$0.95$1.05ViewN/AView Earnings Details
11/2/2010Q3 2010$0.77$0.87ViewN/AView Earnings Details
8/12/2010Q2 2010$0.68$0.71ViewN/AView Earnings Details
4/29/2010Q1 2010$0.63$0.76ViewN/AView Earnings Details
2/2/2010Q4 2009$0.66$0.70ViewN/AView Earnings Details
11/2/2009Q3 2009$0.49$0.66ViewN/AView Earnings Details
8/18/2009Q2 2009$0.46$0.50ViewN/AView Earnings Details
5/7/2009Q1 2009$0.45$0.51ViewN/AView Earnings Details
2/3/2009Q4 2008$0.50$0.46ViewN/AView Earnings Details
11/6/2008Q3 2008$0.42$0.41ViewN/AView Earnings Details
8/18/2008Q2 2008$0.40$0.39ViewN/AView Earnings Details
5/6/2008Q1 2008$0.42$0.44ViewN/AView Earnings Details
2/5/2008Q4 2007$0.34$0.36ViewN/AView Earnings Details
(Earnings results data provided by Zacks Investment Research)

Estimates

Perrigo (NYSE:PRGO) Earnings Estimates

2018 EPS Consensus Estimate: $5.40
QuarterNumber of EstimatesLow EstimateHigh EstimateAverage Estimate
Q1 20182$1.12$1.24$1.18
Q2 20182$1.32$1.40$1.36
Q3 20182$1.36$1.38$1.37
Q4 20182$1.47$1.50$1.49
(Earnings estimates data provided by Zacks Investment Research)

Dividends

Perrigo (NYSE:PRGO) Dividend Information

Next Dividend:3/20/2018
Annual Dividend:$0.64
Dividend Yield:0.73%
Dividend Growth:15.10% (3 Year Average)
Payout Ratio:-6.99% (Trailing 12 Months of Earnings)
13.09% (Based on This Year's Estimates)
12.03% (Based on Next Year's Estimates)
Track Record:15 Years of Consecutive Dividend Growth
Frequency:Quarterly Dividend
Dividend Payments by Quarter for Perrigo (NYSE:PRGO)

Perrigo (NYSE:PRGO) Dividend History by Quarter

AnnouncedPeriodAmountYieldEx-Dividend DateRecord DatePayable Date
2/15/2018quarterly$0.190.872359963269054%3/1/20183/2/20183/20/2018
11/2/2017quarterly$0.160.77%11/30/201712/1/201712/19/2017
8/8/2017Quarterly$0.160.96%8/23/20178/25/20179/12/2017
5/3/2017quarterly$0.160.88%5/24/20175/26/20176/13/2017
2/21/2017quarterly$0.160.76%3/1/20173/3/20173/21/2017
11/8/2016quarterly$0.150.69%11/22/201611/25/201612/13/2016
8/2/2016quarterly$0.150.62%8/24/20168/26/20169/13/2016
4/26/2016$0.155/25/20165/27/20166/14/2016
4/26/2016quarterly$0.155/25/20165/27/20166/14/2016
2/16/2016quarterly$0.152/24/20162/26/20163/15/2016
11/4/2015quarterly$0.1311/24/201511/27/201512/15/2015
8/12/2015quarterly$0.138/26/20158/28/20159/15/2015
4/29/2015quarterly$0.130.27%5/27/20155/29/20156/16/2015
1/27/2015quarterly$0.132/25/20152/27/20153/17/2015
11/3/2014quarterly$0.110.26%11/27/201411/28/201412/16/2014
8/13/2014quarterly$0.110.28%8/27/20148/29/20149/16/2014
4/28/2014quarterly$0.110.29%5/28/20145/30/20146/17/2014
1/29/2014quarterly$0.110.27%2/26/20142/28/20143/18/2014
11/6/2013quarterly$0.090.25%11/26/201311/29/201312/17/2013
8/14/2013quarterly$0.090.29%8/28/20138/30/20139/17/2013
5/2/2013quarterly$0.090.3%5/29/20135/31/20136/18/2013
1/31/2013quarterly$0.090.34%2/27/20133/1/20133/19/2013
(Data available from 1/1/2013 forward)

Insider Trades

Perrigo (NYSE PRGO) Insider Trading and Institutional Ownership History

Insider Ownership Percentage: 6.90%
Institutional Ownership Percentage: 82.44%
Insider Trades by Quarter for Perrigo (NYSE:PRGO)
Institutional Ownership by Quarter for Perrigo (NYSE:PRGO)

Perrigo (NYSE PRGO) Insider Trades by Quarter

Transaction DateInsider NameTitleBuy/SellNumber of SharesAverage Share PriceTotal TransactionShares Held After TransactionDetails
12/28/2017Todd W KingmaVPSell1,500$88.52$132,780.0019,565View SEC Filing  
12/28/2017Todd W KingmaVPSell1,500$88.52$132,780.0019,565View SEC Filing  
12/14/2017John WesolowskiEVPBuy700$85.80$60,060.00View SEC Filing  
12/7/2017John WesolowskiEVPSell450$83.09$37,390.50View SEC Filing  
11/29/2017John WesolowskiEVPSell388$87.20$33,833.60248View SEC Filing  
11/16/2017Thomas FarringtonEVPSell213$87.26$18,586.383,347View SEC Filing  
9/12/2017Jeffrey NeedhamEVPSell3,595$89.49$321,716.5510,118View SEC Filing  
9/7/2017Sharon KochanEVPSell318$81.36$25,872.4810,231View SEC Filing  
8/31/2017Sharon KochanEVPSell1,500$79.03$118,545.0010,349View SEC Filing  
8/30/2017Thomas FarringtonEVPSell616$76.90$47,370.402,724View SEC Filing  
8/18/2017Thomas FarringtonEVPSell865$78.40$67,816.002,870View SEC Filing  
11/25/2016Judy L BrownEVPSell2,097$89.44$187,555.6810,007View SEC Filing  
11/21/2016Geoffrey M ParkerDirectorBuy2,500$88.75$221,875.00View SEC Filing  
10/24/2016Judy L BrownEVPSell2,092$90.42$189,158.6412,104View SEC Filing  
9/26/2016Judy L BrownCFOSell2,096$96.76$202,808.9614,196View SEC Filing  
9/26/2016Thomas FarringtonEVPSell1,110$96.76$107,403.602,970View SEC Filing  
9/9/2016Gary K Kunkle JrDirectorSell5,814$89.95$522,969.3031,501View SEC Filing  
9/8/2016Herman Morris JrDirectorSell1,073$90.96$97,600.0810,425View SEC Filing  
8/26/2016Judy L BrownEVPSell2,095$88.28$184,946.6016,292View SEC Filing  
4/13/2016Judy L BrownCFOSell2,776$126.22$350,386.7213,924View SEC Filing  
3/18/2016Michael J JandernoaDirectorSell761$128.29$97,628.698,611View SEC Filing  
3/2/2016Sharon KochanEVPSell1,490$125.28$186,667.205,883View SEC Filing  
2/24/2016Judy L BrownCFOSell2,776$123.73$343,474.4813,924View SEC Filing  
1/6/2016Judy L. BrownCFOSell27,737$142.41$3,950,026.1712,429View SEC Filing  
12/28/2015Joseph C. PapaChairmanSell10,183$147.07$1,497,613.81118,515View SEC Filing  
8/25/2015John T. HendricksonEVPSell1,737$181.37$315,039.69View SEC Filing  
8/25/2015Todd W. KingmaVPSell1,715$181.37$311,049.5510,320View SEC Filing  
8/24/2015John T. HendricksonEVPSell4,468$177.68$793,874.241,737View SEC Filing  
4/29/2015Todd W KingmaVPSell1,700$190.27$323,459.00View SEC Filing  
4/14/2015John T HendricksonEVPSell8,800$200.27$1,762,376.00View SEC Filing  
4/13/2015Todd W KingmaVPSell1,300$198.44$257,972.00View SEC Filing  
3/13/2015Jatin ShahSVPSell2,000$165.50$331,000.00View SEC Filing  
10/1/2014Judy L BrownCFOSell3,515$150.72$529,780.80View SEC Filing  
9/3/2014Sharon KochanEVPSell1,116$150.00$167,400.00View SEC Filing  
9/3/2014Todd W KingmaVPSell2,250$149.65$336,712.50View SEC Filing  
9/2/2014Judy L BrownCFOSell3,515$149.32$524,859.80View SEC Filing  
9/2/2014Thomas FarringtonVPSell1,741$150.36$261,776.76View SEC Filing  
8/27/2014Michael Robert StewartVPSell4,519$148.78$672,336.82View SEC Filing  
8/26/2014Jeffrey NeedhamVPSell10,205$148.54$1,515,850.70View SEC Filing  
8/26/2014Judy L BrownCFOSell4,827$148.87$718,595.49View SEC Filing  
8/25/2014John T HendricksonEVPSell2,533$148.44$375,998.52View SEC Filing  
5/15/2014Ran GottfriedDirectorSell1,000$131.25$131,250.0012,159View SEC Filing  
3/24/2014Joseph PapaChairmanSell10,000$157.72$1,577,200.0095,500View SEC Filing  
1/16/2014Joseph PapaChairmanSell5,000$157.59$787,950.0096,655View SEC Filing  
12/12/2013Gary CohenDirectorSell4,632$152.52$706,472.6411,868View SEC Filing  
12/12/2013Joseph PapaChairmanSell15,000$150.12$2,251,800.0096,655View SEC Filing  
12/9/2013Michael JandernoaDirectorSell128,620$155.30$19,974,686.00868View SEC Filing  
11/25/2013Louis YuVPSell2,292$155.51$356,428.928,548View SEC Filing  
11/21/2013Judy BrownCFOSell9,988$154.74$1,545,543.127,445View SEC Filing  
11/20/2013John HendricksonEVPSell8,400$152.80$1,283,520.00View SEC Filing  
11/4/2013Ran GottfriedDirectorSell2,275$143.36$326,144.0011,609View SEC Filing  
9/24/2013Joseph PapaChairmanSell15,000$124.60$1,869,000.00116,655View SEC Filing  
9/18/2013John HendricksonEVPSell2,161$125.00$270,125.00View SEC Filing  
9/11/2013Michael Robert StewartVPSell5,063$123.37$624,622.31View SEC Filing  
9/9/2013Louis YuVPSell1,852$124.11$229,851.72View SEC Filing  
9/6/2013John T HendricksonEVPSell1,000$123.46$123,460.00View SEC Filing  
9/4/2013John T HendricksonEVPSell2,000$123.92$247,840.00View SEC Filing  
9/3/2013Judy BrownCFOSell2,500$122.07$305,175.0017,433View SEC Filing  
8/30/2013Jeffrey NeedhamVPSell6,585$120.47$793,294.955,199View SEC Filing  
8/29/2013Sharon KochanVPSell3,467$120.98$419,437.665,541View SEC Filing  
8/27/2013Joseph PapaChairmanSell15,000$117.64$1,764,600.00118,455View SEC Filing  
8/26/2013John HendricksonEVPSell2,099$119.15$250,095.85View SEC Filing  
8/26/2013Judy BrownCFOSell3,424$119.28$408,414.7217,433View SEC Filing  
8/20/2013John HendricksonEVPSell1,676$118.56$198,706.56View SEC Filing  
8/20/2013Judy BrownCFOSell2,804$118.58$332,498.3217,433View SEC Filing  
8/20/2013Thomas FarringtonVPSell1,658$119.86$198,727.881,040View SEC Filing  
8/16/2013Todd KingmaVPSell1,250$120.00$150,000.0017,065View SEC Filing  
7/19/2013Todd W KingmaVPSell1,250$129.37$161,712.50View SEC Filing  
7/11/2013Joseph C PapaChairmanSell10,000$128.54$1,285,400.00View SEC Filing  
7/9/2013John T HendricksonEVPSell2,161$125.00$270,125.00View SEC Filing  
6/14/2013Joseph C PapaChairmanSell10,000$118.39$1,183,900.00View SEC Filing  
6/14/2013Todd W KingmaVPSell1,250$118.00$147,500.00View SEC Filing  
6/4/2013Judy L BrownCFOSell2,500$116.38$290,950.00View SEC Filing  
5/14/2013Sharon KochanVPSell2,647$119.64$316,687.085,492View SEC Filing  
(Data available from 1/1/2013 forward)

Headlines

Perrigo (NYSE PRGO) News Headlines

Source:
DateHeadline
Quadrature Capital Ltd Buys 48,477 Shares of Perrigo Company plc (PRGO)Quadrature Capital Ltd Buys 48,477 Shares of Perrigo Company plc (PRGO)
www.americanbankingnews.com - February 24 at 4:20 PM
Perrigo (PRGO) Given a $107.00 Price Target by Cantor Fitzgerald AnalystsPerrigo (PRGO) Given a $107.00 Price Target by Cantor Fitzgerald Analysts
www.americanbankingnews.com - February 23 at 8:00 PM
Is a Beat in the Cards for Perrigo (PRGO) in Q4 Earnings? - NasdaqIs a Beat in the Cards for Perrigo (PRGO) in Q4 Earnings? - Nasdaq
www.nasdaq.com - February 23 at 8:47 AM
Is a Beat in the Cards for Perrigo (PRGO) in Q4 Earnings?Is a Beat in the Cards for Perrigo (PRGO) in Q4 Earnings?
finance.yahoo.com - February 21 at 5:11 PM
Perrigo (PRGO) Names Ronald L. Winowiecki as CFOPerrigo (PRGO) Names Ronald L. Winowiecki as CFO
www.streetinsider.com - February 20 at 5:27 PM
Perrigo Appoints Ronald L. Winowiecki as Chief Financial OfficerPerrigo Appoints Ronald L. Winowiecki as Chief Financial Officer
finance.yahoo.com - February 20 at 5:27 PM
Does Perrigo Company plc’s (NYSE:PRGO) Past Performance Indicate A Stronger Future?Does Perrigo Company plc’s (NYSE:PRGO) Past Performance Indicate A Stronger Future?
finance.yahoo.com - February 20 at 5:27 PM
Perrigo (PRGO) Confirms Patent Challenge For Generic Version Of Finacea Foam, 15% - StreetInsider.comPerrigo (PRGO) Confirms Patent Challenge For Generic Version Of Finacea Foam, 15% - StreetInsider.com
www.streetinsider.com - February 20 at 8:35 AM
Perrigo (PRGO) Names Ronald L. Winowiecki as CFO - StreetInsider.comPerrigo (PRGO) Names Ronald L. Winowiecki as CFO - StreetInsider.com
www.streetinsider.com - February 20 at 8:35 AM
Perrigo Confirms Patent Challenge For Generic Version Of Finacea® Foam, 15%Perrigo Confirms Patent Challenge For Generic Version Of Finacea® Foam, 15%
finance.yahoo.com - February 20 at 8:35 AM
Perrigo (PRGO) Scheduled to Post Earnings on TuesdayPerrigo (PRGO) Scheduled to Post Earnings on Tuesday
www.americanbankingnews.com - February 20 at 3:28 AM
Global Over-the-Counter (OTC) Drug Markets Report 2018: Perrigo Is the Leading Off-Brand OTC Drug CompanyGlobal Over-the-Counter (OTC) Drug Markets Report 2018: Perrigo Is the Leading Off-Brand OTC Drug Company
www.prnewswire.com - February 19 at 2:31 PM
Zacks: Analysts Anticipate Perrigo Company plc (PRGO) Will Post Quarterly Sales of $1.25 BillionZacks: Analysts Anticipate Perrigo Company plc (PRGO) Will Post Quarterly Sales of $1.25 Billion
www.americanbankingnews.com - February 18 at 1:48 AM
Zacks: Brokerages Expect Perrigo Company plc (PRGO) Will Post Earnings of $1.24 Per ShareZacks: Brokerages Expect Perrigo Company plc (PRGO) Will Post Earnings of $1.24 Per Share
www.americanbankingnews.com - February 16 at 9:14 PM
Cantor Fitzgerald Analysts Give Perrigo (PRGO) a $107.00 Price TargetCantor Fitzgerald Analysts Give Perrigo (PRGO) a $107.00 Price Target
www.americanbankingnews.com - February 16 at 7:10 PM
Perrigo Announces Quarterly DividendPerrigo Announces Quarterly Dividend
finance.yahoo.com - February 15 at 5:04 PM
Perrigo Company plc (PRGO) Plans Dividend Increase - $0.19 Per SharePerrigo Company plc (PRGO) Plans Dividend Increase - $0.19 Per Share
www.americanbankingnews.com - February 15 at 10:26 AM
Perrigo To Release Fourth Quarter And Calendar Year 2017 Financial Results On February 27, 2018Perrigo To Release Fourth Quarter And Calendar Year 2017 Financial Results On February 27, 2018
finance.yahoo.com - February 8 at 8:27 AM
Perrigo Company (PRGO) Receives Average Recommendation of "Hold" from BrokeragesPerrigo Company (PRGO) Receives Average Recommendation of "Hold" from Brokerages
www.americanbankingnews.com - February 2 at 1:59 PM
$1.25 Billion in Sales Expected for Perrigo Company (PRGO) This Quarter$1.25 Billion in Sales Expected for Perrigo Company (PRGO) This Quarter
www.americanbankingnews.com - February 1 at 2:40 AM
Perrigo Announces Tentative FDA Approval For The Generic Version Of Soolantra® Cream, 1%Perrigo Announces Tentative FDA Approval For The Generic Version Of Soolantra® Cream, 1%
finance.yahoo.com - January 30 at 10:15 AM
Q1 2018 EPS Estimates for Perrigo Company Lowered by Leerink Swann (PRGO)Q1 2018 EPS Estimates for Perrigo Company Lowered by Leerink Swann (PRGO)
www.americanbankingnews.com - January 29 at 2:04 AM
Stock Traders Buy High Volume of Put Options on Perrigo (PRGO)Stock Traders Buy High Volume of Put Options on Perrigo (PRGO)
www.americanbankingnews.com - January 27 at 1:44 AM
Perrigo (PRGO) Reports Tentative FDA Approval for Generic Version Of Onexton GelPerrigo (PRGO) Reports Tentative FDA Approval for Generic Version Of Onexton Gel
www.streetinsider.com - January 26 at 3:58 PM
Perrigo Announces Tentative FDA Approval For The Generic Version Of Onexton® GelPerrigo Announces Tentative FDA Approval For The Generic Version Of Onexton® Gel
finance.yahoo.com - January 26 at 3:58 PM
BRIEF-Perrigo Announces Final FDA Approval Of A Generic Version Of Estrace CreamBRIEF-Perrigo Announces Final FDA Approval Of A Generic Version Of Estrace Cream
www.reuters.com - January 24 at 10:17 AM
Perrigo Announces Final FDA Approval And Launch Of An AB Rated Generic Version Of Epiduo® GelPerrigo Announces Final FDA Approval And Launch Of An AB Rated Generic Version Of Epiduo® Gel
finance.yahoo.com - January 24 at 10:17 AM
Oppenheimer Weighs in on Perrigo Companys Q4 2017 Earnings (PRGO)Oppenheimer Weighs in on Perrigo Company's Q4 2017 Earnings (PRGO)
www.americanbankingnews.com - January 24 at 8:12 AM
Oppenheimer Weighs in on Perrigo Companys FY2017 Earnings (PRGO)Oppenheimer Weighs in on Perrigo Company's FY2017 Earnings (PRGO)
www.americanbankingnews.com - January 23 at 8:54 AM
Perrigos (PRGO) "Buy" Rating Reiterated at Cantor FitzgeraldPerrigo's (PRGO) "Buy" Rating Reiterated at Cantor Fitzgerald
www.americanbankingnews.com - January 19 at 12:30 PM
Zacks: Analysts Anticipate Perrigo Company (PRGO) Will Announce Quarterly Sales of $1.24 BillionZacks: Analysts Anticipate Perrigo Company (PRGO) Will Announce Quarterly Sales of $1.24 Billion
www.americanbankingnews.com - January 15 at 2:36 AM
Zacks: Brokerages Anticipate Perrigo Company (PRGO) Will Announce Earnings of $1.23 Per ShareZacks: Brokerages Anticipate Perrigo Company (PRGO) Will Announce Earnings of $1.23 Per Share
www.americanbankingnews.com - January 13 at 11:32 PM
Perrigo (PRGO) PT Set at $107.00 by Cantor FitzgeraldPerrigo (PRGO) PT Set at $107.00 by Cantor Fitzgerald
www.americanbankingnews.com - January 12 at 1:26 PM
Perrigo (PRGO) Hits 52-Week High: Whats Driving the Stock?Perrigo (PRGO) Hits 52-Week High: What's Driving the Stock?
www.zacks.com - January 12 at 10:21 AM
Elagolix May Advance the Treatment Paradigm in Women’s HealthElagolix May Advance the Treatment Paradigm in Women’s Health
finance.yahoo.com - January 11 at 10:45 AM
Perrigo Trying To Close In On Key Technical BenchmarkPerrigo Trying To Close In On Key Technical Benchmark
finance.yahoo.com - January 11 at 10:45 AM
Recent Developments for MylanRecent Developments for Mylan
finance.yahoo.com - January 11 at 10:45 AM
Incoming Perrigo CEO Brings Strong Operations ExperienceIncoming Perrigo CEO Brings Strong Operations Experience
finance.yahoo.com - January 9 at 4:39 PM
S&P 500 Movers: PRGO, STX - NasdaqS&P 500 Movers: PRGO, STX - Nasdaq
www.nasdaq.com - January 8 at 4:41 PM
Perrigo (PRGO) Announces Uwe Rohrhoff As President & CEO; Effective January 15, 2018 - StreetInsider.comPerrigo (PRGO) Announces Uwe Rohrhoff As President & CEO; Effective January 15, 2018 - StreetInsider.com
www.streetinsider.com - January 8 at 4:41 PM
Perrigo Company (PRGO) Given Average Rating of "Hold" by BrokeragesPerrigo Company (PRGO) Given Average Rating of "Hold" by Brokerages
www.americanbankingnews.com - January 8 at 12:40 PM
Equities Analysts Offer Predictions for Perrigo Companys FY2017 Earnings (PRGO)Equities Analysts Offer Predictions for Perrigo Company's FY2017 Earnings (PRGO)
www.americanbankingnews.com - January 5 at 7:42 AM
Leerink Swann Comments on Perrigo Companys Q1 2018 Earnings (PRGO)Leerink Swann Comments on Perrigo Company's Q1 2018 Earnings (PRGO)
www.americanbankingnews.com - January 4 at 10:16 AM
Perrigo Gets Tentative FDA Approval For Generic Version Of ProlensaPerrigo Gets Tentative FDA Approval For Generic Version Of Prolensa
www.nasdaq.com - January 3 at 9:35 AM
Perrigo Announces Tentative FDA Approval For The Generic Version Of Prolensa® Ophthalmic Solution 0.07%Perrigo Announces Tentative FDA Approval For The Generic Version Of Prolensa® Ophthalmic Solution 0.07%
finance.yahoo.com - January 3 at 9:35 AM
Perrigo (PRGO) Coverage Initiated by Analysts at Leerink SwannPerrigo (PRGO) Coverage Initiated by Analysts at Leerink Swann
www.americanbankingnews.com - January 2 at 5:18 PM
Perrigo To Present At The 36th Annual J.P. Morgan Healthcare ConferencePerrigo To Present At The 36th Annual J.P. Morgan Healthcare Conference
finance.yahoo.com - January 2 at 10:12 AM
Perrigo Company (PRGO) VP Todd W. Kingma Sells 1,500 SharesPerrigo Company (PRGO) VP Todd W. Kingma Sells 1,500 Shares
www.americanbankingnews.com - January 1 at 4:56 AM
$1.24 Billion in Sales Expected for Perrigo Company (PRGO) This Quarter$1.24 Billion in Sales Expected for Perrigo Company (PRGO) This Quarter
www.americanbankingnews.com - December 30 at 4:32 PM
Canaccord Genuity Analysts Give Perrigo (PRGO) a $100.00 Price TargetCanaccord Genuity Analysts Give Perrigo (PRGO) a $100.00 Price Target
www.americanbankingnews.com - December 29 at 11:34 PM

SEC Filings

Perrigo (NYSE:PRGO) SEC Filings

This page is loading this company's SEC Filings. Please wait...

Social Media

Financials

Perrigo (NYSE:PRGO) Income Statement, Balance Sheet and Cash Flow Statement

Chart

Perrigo (NYSE PRGO) Stock Chart for Saturday, February, 24, 2018

Loading chart…

This page was last updated on 2/24/2018 by MarketBeat.com Staff

Enter your email address below to receive a concise daily summary of analysts' upgrades, downgrades and new coverage with MarketBeat.com's FREE daily email newsletter.